Share on StockTwits

GlycoMimetics’ (NASDAQ:GLYC) lock-up period is set to end on Wednesday, July 9th. GlycoMimetics had issued 7,000,000 shares in its IPO on January 10th, Analyst Ratings News reports. The total size of the offering was $56,000,000 based on an initial share price of $8.00. After the end of the company’s lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Separately, analysts at Stifel Nicolaus raised their price target on shares of GlycoMimetics from $14.00 to $16.00 in a research note on Tuesday, April 15th. They now have a “buy” rating on the stock.

GlycoMimetics (NASDAQ:GLYC) traded down 2.75% on Friday, hitting $9.21. 143,579 shares of the company’s stock traded hands. GlycoMimetics has a one year low of $6.02 and a one year high of $18.99. The stock has a 50-day moving average of $7.19 and a 200-day moving average of $10.90. The company’s market cap is $173.1 million.

GlycoMimetics (NASDAQ:GLYC) last released its earnings data on Friday, May 9th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by $0.01. Analysts expect that GlycoMimetics will post $0.09 EPS for the current fiscal year.

GlycoMimetics, Inc (NASDAQ:GLYC) is a clinical-stage biotechnology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.